Anika signs US licensing deal with DePuy Mitek for Monovisc
This article was originally published in Scrip
Executive Summary
Anika Therapeutics has signed an exclusive, multi-year US licensing and supply agreement with the orthopedic sports medicine company, DePuy Mitek, for its Monovisc product, a purified, high-molecular weight form of hyaluronic acid for treating pain in patients with osteoarthritis of the knee.